This idea is experimentally supported by the strong reduction in liver metastasis development observed following early DDR1 inhibition by nilotinib treatment when most inoculated CRC cells have already reached the liver and the strong diminution of nuclear β‐catenin activity at the front of the metastatic tumour. Here, DDR1 is linked to neoplasm.